Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.

Thewjitcharoen YotsaponAmia Jones ElizabethSiriwan ButadejSoontaree NakasatienPhawinpon ChotwanviratEkgaluck WanothayarojSirinate KrittiyawongTinapa HimathongkamThep Himathongkam

Published in: BMC endocrine disorders (2019)

Despite the practicality and validity of HbA1c as a diagnostic test, our study suggested that HbA1c as a screening tool for diabetes in high-risk Thai patients is much inferior to OGTT. With limitations of HbA1c, physicians should continue to advocate OGTT as a screening tool for the identification of dysglycemic status in high-risk Thai patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
cardiovascular disease
primary care
metabolic syndrome
patient reported outcomes